In a recent study, TGFBI, PI3, TLL1 and MMP17 were predicted to be among the 19 genes that comprise the TME-related high grade serous ovarian carcinoma prognostic genetic panel (Belotti et al., 2022). This evidence concerns the gene TLL1 and ovarian serous carcinoma.